TRI LOCUM PARTNERS LP – Celldex Therapeutics, Inc. Transaction History
TRI LOCUM PARTNERS LP portfolio value:
$6.70M
portfolio value
TRI LOCUM PARTNERS LP quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +80.53% | 106.42K shares | 3.14M | $28.11 | 238.56K |
| Q2 2022 | share | Decrease | -65.53% | -251.17K shares | -9.49M | $26.96 | 132.14K |
| Q1 2022 | share | Increase | 0.00% | 383.31K shares | 13.05M | $34.06 | 383.31K |
| Q3 2021 | share | Decrease | -100.00% | -175.30K shares | -5.86M | $53.99 | 0 |
| Q2 2021 | share | Decrease | -10.86% | -21.36K shares | 1.81M | $33.44 | 175.30K |
| Q1 2021 | share | Increase | 0.00% | 196.67K shares | 4.05M | $20.6 | 196.67K |